Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system (Q46807755)

25 December 2017

title

Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system (English)

1 reference

25 December 2017

1 reference

T Sherrin

1

1 reference

25 December 2017

C Todorovic

2

1 reference

25 December 2017

T Zeyda

3

1 reference

25 December 2017

C H Tan

4

1 reference

25 December 2017

P T H Wong

5

1 reference

25 December 2017

Y-Z Zhu

6

1 reference

25 December 2017

J Spiess

7

1 reference

25 December 2017

language of work or name

English

0 references

publication date

15 January 2008

1 reference

25 December 2017

published in

Molecular Psychiatry

1 reference

25 December 2017

volume

14

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

291-307

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.mp.4002121

exact match

0 references

cites work

The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

New peptide in the vertebrate CNS reacting with antigastrin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

CCK in anxiety and cognitive processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Reduced anxious behavior in mice lacking the CCK2 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Primary structure of corticotropin-releasing factor from ovine hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Genetic approaches to the study of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Contextual fear, gestalt memories, and the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Distribution of cholecystokinin immunoreactivity in the BALB/c mouse forebrain: an immunocytochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Distribution and colocalization of cholecystokinin with the prohormone convertase enzymes PC1, PC2, and PC5 in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

A modern learning theory perspective on the etiology of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

CCK-antagonists in a rat exposed to acute stress: implication for anxiety associated with post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Rats displaying distinct exploratory activity also have different expression patterns of gamma-aminobutyric acid- and cholecystokinin-related genes in brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Are different parts of the extended amygdala involved in fear versus anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

The emotional brain, fear, and the amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Simultaneous induction of long-term potentiation in the hippocampus and the amygdala by entorhinal cortex activation: mechanistic and temporal profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Neuronal signalling of fear memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Neuropeptide-containing neurons of the cerebral cortex are also GABAergic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

Cholecystokinin peptides and receptors in the rat brain during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Relationship between fos production and classical fear conditioning: effects of novelty, latent inhibition, and unconditioned stimulus preexposure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Autoradiographic localization of cholecystokinin receptors in rodent brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Projections from the lateral, basal, and accessory basal nuclei of the amygdala to the hippocampal formation in rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Combinatorial amygdalar inputs to hippocampal domains and hypothalamic behavior systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Transcriptional response to corticotropin-releasing factor in AtT-20 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Inflammation and brain function under basal conditions and during long-term elevation of brain corticotropin-releasing hormone levels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Separate populations of cholecystokinin and 5-hydroxytryptamine-containing neuronal cells in the rat dorsal raphe, and their contribution to the ascending raphe projections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002121

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4002121

1 reference

25 December 2017

PubMed ID

18195718

1 reference

25 December 2017